Is atenolol an angiotensin‑II receptor blocker (ARB) for a 55‑year‑old woman with newly diagnosed mild hypertension?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 29, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

No, atenolol is NOT an ARB

Atenolol is a beta-blocker (specifically a beta-1 selective adrenergic receptor blocker), not an angiotensin-II receptor blocker (ARB). These are completely different drug classes with distinct mechanisms of action 1.

Drug Classification

Atenolol works by blocking beta-1 adrenergic receptors in the heart, which:

  • Reduces heart rate and cardiac output
  • Decreases blood pressure through cardiac effects
  • Has no effect on the renin-angiotensin system 1

In contrast, ARBs (such as losartan, irbesartan, olmesartan, telmisartan, and valsartan) block angiotensin-II type 1 (AT1) receptors, preventing angiotensin-II from exerting its vasoconstrictive and aldosterone-releasing effects 2, 3.

Critical Clinical Distinction for Your Patient

For a 55-year-old woman with newly diagnosed mild hypertension, this distinction matters significantly:

Current Guidelines Recommend:

  • First-line agents: ACE inhibitors, ARBs, calcium channel blockers (CCBs), or thiazide/thiazide-like diuretics 4, 5
  • Beta-blockers (including atenolol) are NOT recommended as first-line monotherapy for uncomplicated hypertension 5

Beta-blockers Should Be Reserved For:

  • Compelling indications such as:
    • Angina pectoris
    • Post-myocardial infarction
    • Heart failure with reduced ejection fraction
    • Heart rate control needs 5

Important Contraindication

If your patient is of childbearing potential or planning pregnancy, atenolol is specifically contraindicated 4. The 2025 AHA/ACC guidelines give a Class 3 (Harm) recommendation against using atenolol in pregnancy due to fetal risks, including small-for-gestational-age infants 4, 1.

For This Population:

  • ARBs are also contraindicated in pregnancy
  • Preferred agents: labetalol or extended-release nifedipine 4

Bottom Line

Atenolol and ARBs are fundamentally different drug classes. For uncomplicated hypertension in a 55-year-old woman, an ARB (combined with a CCB or thiazide diuretic) would be guideline-concordant first-line therapy 5, whereas atenolol would not be recommended unless specific cardiac indications exist.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.